ARCHIVES

Cvitkovic Responds To Story On March ODAC Meeting.

This article is from The Cancer Letter archive.

Vol. 26 No. 25 | June 23, 2000

Download PDF Visit The Full Archive

Related Articles

US Oncology Begins Trial Of Taxotere And Xeloda

September 27, 2002

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Decline In Breast Cancer May Be Related to Drop In HT

March 25, 2011

California approves $3 billion program for stem-cell research.

November 5, 2004

NCAB To Seek Changes In Cancer Act Renewal, Budget Improvements

November 20, 1987

The FY 1984 Bypass Budget: How NCI Would Spend the Money

July 9, 1982